Immunosuppressant is a class of medicine that inhibit or decrease the intensity of the immune response in the body. Most of these medications are used to allow the body less likely to resist a transplanted organ .In solid organ transplanted organ. In solid organ transplantation immunosuppressive agents are needed for the activation of early -stage immunosuppression ,the management of organ rejection .The emergence of novel agent and improvement in immune suppression regimens after transplantation are significant factor leading to this progress .However, these drugs also increase the risk of infection , cancers and specific adverse side effects specific to each agent in patients particularly in pregnant women and fertility issues. Corona virus disease being hot topic of debate is has given positive outcome to immunosuppressive drug how ever need more attention I future. Transplant centres across the utilize multiple immunosuppression protocol’s nevertheless , each patient can require an individually formulated immunosuppression regimen to manage the advantages and possible damage of treatment thus eliminating the likelihood of the primary disease recurrence.
Choose the style your journal or department asks for, then copy it.
Every version below is generated from this paper's own record.
IJRTI — journal style
"Immunosuppressants", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.9, Issue 2, page no.103 - 107, February-2024, Available :https://ijrti.org/papers/IJRTI2402018.pdf
APA — 7th edition
Reddy, D. R. B., Malleswari, K., & Renuka, M. (2024). Immunosuppressants. International Journal for Research Trends and Innovation, 9(2), 103 - 107. https://ijrti.org/viewpaperforall.php?paper=IJRTI2402018
MLA — 9th edition
Reddy, D.Rama Brahma, et al. "Immunosuppressants." International Journal for Research Trends and Innovation, vol. 9, no. 2, 2024, pp. 103 - 107, https://ijrti.org/viewpaperforall.php?paper=IJRTI2402018.
Chicago — 17th, bibliography
Reddy, D.Rama Brahma, K. Malleswari, and Mudamanchu Renuka. "Immunosuppressants." International Journal for Research Trends and Innovation 9, no. 2 (2024): 103 - 107. https://ijrti.org/viewpaperforall.php?paper=IJRTI2402018.
Harvard — author–date
Reddy, D.R.B., Malleswari, K. and Renuka, M. (2024) 'Immunosuppressants', International Journal for Research Trends and Innovation, 9(2), pp. 103 - 107. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2402018
IEEE — numbered reference
D. R. B. Reddy, K. Malleswari and M. Renuka, "Immunosuppressants," IJRTI, vol. 9, no. 2, pp. 103 - 107, Feb. 2024.
Reddy DRB, Malleswari K, Renuka M. Immunosuppressants. IJRTI. 2024;9(2):103 - 107. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2402018
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2402018,
author = {D.Rama Brahma Reddy and K. Malleswari and Mudamanchu Renuka},
title = {Immunosuppressants},
journal = {International Journal for Research Trends and Innovation},
volume = {9},
number = {2},
pages = {103 - 107},
year = {2024},
month = {February},
issn = {2456-3315},
url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2402018}
}
RIS — EndNote, RefWorks
TY - JOUR
AU - Reddy, D.Rama Brahma
AU - Malleswari, K.
AU - Renuka, Mudamanchu
TI - Immunosuppressants
T2 - International Journal for Research Trends and Innovation
JA - IJRTI
VL - 9
IS - 2
PY - 2024
SN - 2456-3315
UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2402018
SP - 103
EP - 107
ER -
International Journal for Research Trends and InnovationPublished by IJRTI (JW Publication)
2456-3315ISSN
10.57Impact Factor
2016ESTD Year
OpenAccess
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.
Disclaimer:
The content, data and findings in this article are based on the authors’ research and have been
peer-reviewed for academic purposes only. Readers are advised to verify all information before practical
or commercial use. The journal and its editorial board are not liable for any errors, losses or
consequences arising from its use.
Declarations
Funding
No external funding was received for this study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Acknowledgements
The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.